… expediting Parkinson’s disease research, working tirelessly to advance global opportunities in neuroscience. Questions? … If you have questions or would like more information on how MJFF can support your interests, get in touch: … MJFF. Read the Report Target De-risking Initiatives MJFF is committed to supporting efforts that de-risk early-stage …

… Although Congress has recently proposed changes to our health care system , the Affordable Care Act (also … bill is signed into law. Of importance to the Parkinson's community is a section within the ACA (referred to as the … to co-sponsor these pieces of legislation , which have support from lawmakers in both parties. We need the …

… Editor’s Note: John M. Baumann is a motivational speaker and … your inner strength to eat healthy, exercise beyond your comfort zone, and stay engaged with what and who you love … you have Parkinson’s?” Then the awkward next sentence: “How are you doing?” We all have bad days, but my first …

… California-based biotech Avanir Pharmaceuticals today announced funding from The Michael J. Fox Foundation … treat dyskinesia in people with Parkinson’s. The study will test the safety and efficacy of their drug called AVP-923 … the trial will be a proof-of-concept study designed to compare their drug with a placebo treatment. AVP-923 is also …

… The biology behind what causes Parkinson’s disease (PD) is complex, with only about a quarter of cases with clear … around you – plays a key role in PD. Emerging research is showing environmental exposures to things like pesticides and pollution may interact with a …

… Lack of objective tests to diagnose Parkinson's disease (PD) challenges drug … of Parkinson's patients and what it smells like and then how can we detect it," says Samantha Hutten, PhD, senior … led by Mark Baron, MD, professor of neurology at Virginia Commonwealth University, breaks down what eye movement means …